| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 83 |
| Opened positions | 13 |
| Closed positions | 18 |
| Increased positions | 21 |
| Reduced positions | 25 |
| 13F shares | Current |
|---|---|
| Total value | 27.84 bn |
| Total shares | 210.41 mm |
| Total puts | 33.50 k |
| Total calls | 65.50 k |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| KfW | 114.19 mm | $988.89 mm |
| dievini Hopp BioTech holding GmbH & Co KG | 70.18 mm | $607.77 mm |
| GSK GSK | 16.59 mm | $0.00 |
| Millennium Management | 1.65 mm | $5.62 bn |
| BlackRock | 1.22 mm | $4.17 bn |
| Hettich Christof | 1.02 mm | $7.45 mm |
| UBS UBS | 576.90 k | $1.97 bn |
| Alyeska Investment | 500.00 k | $1.71 bn |
| von Bohlen und Halback Friedrich | 469.76 k | $4.07 mm |
| Point72 Asset Management | 440.51 k | $1.50 bn |
